Table of Contents
• List of Tables and Figures
• Introduction
• Cause of the Disease
• Risk Factors & Prevention
• Diagnosis of the Disease
• Variation by Geography/Ethnicity
• Disease Prognosis & Clinical Course
• Key comorbid conditions/features associated with the disease
• Methodology for quantification of patient numbers
• Top-line estimated incidence for Liver Cancer
• Features of Liver Cancer patients
o AJCC Staging
o Histopathology
o Markers of liver function
o Hepatitis
o Other markers and features of liver cancer
• Abbreviations used in the report
• Other Black Swan Analysis Publications
• Black Swan Analysis Online Patient-Based Databases
• Patient-Based Offering
• Online Pricing Data and Platforms
• References
• Appendix


List of Tables
• Comparison of HCC Staging systems
• American Joint Committee on Cancer (AJCC) TNM Staging for Liver Tumours
• Child Turcotte-Pugh Score
• Incidence of Liver Cancer, total (000s)
• Incidence of Liver Cancer, males (000s)
• Incidence of Liver Cancer, females (000s)
• Liver cancer patients by AJCC stage, total (000s)
• Lymph Nodes and Distant Metastases, total (000s)
• Histopathology of liver cancer patients, total (000s)
• Alpha Fetoprotein (AFP) Positive / Elevated, total (000s)
• Fibrosis Score F1: Severe Fibrosis / Cirrhosis, total (000s)
• Hepatitis B seropositive, total (000s)
• Hepatitis C seropositive, total (000s)
• Cachexia, total (000s)
• PDL-1 expressed, total (000s)
• Abbreviations and Acronyms used in the report
• USA Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• USA Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Canada Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Canada Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• France Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• France Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Germany Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Germany Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Italy Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Italy Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Spain Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Spain Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• UK Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• UK Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Brazil Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Brazil Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Japan Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Japan Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• India Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• India Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• China Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• China Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Turkey Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Turkey Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Australia Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Australia Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Mexico Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Mexico Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Argentina Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Argentina Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Russia Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Russia Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• Saudi Arabia Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• Saudi Arabia Incidence of Liver Cancer by 5-yr age cohort, females (000s)
• South Africa Incidence of Liver Cancer by 5-yr age cohort, males (000s)
• South Africa Incidence of Liver Cancer by 5-yr age cohort, females (000s)